The Size of the Global Europe Dialysis Equipment Market is expected to grow at a CAGR of 5.4% and to reach USD 5.31 billion by 2025, from USD 4.08 billion in 2020 during the forecast period 2020-2025.
Dialysis is the process of removing waste products and excess water from the blood. Dialysis is generally used when kidneys aren’t functioning properly or in case of kidney failure. It is regarded as the supporting measure until kidney transplant is performed or as an alternative measure for the lifetime in case, kidney transplant is not possible. All the equipment used in this process is called Dialysis Equipment.
Some of the major drivers like increasing aging population, rising incidence of kidney diseases, an increasing number of diabetes and hypertension patients, and technological advancements in the healthcare industry are driving the market. However, factors like low awareness about kidney disease treatment and decreasing medical reimbursements for dialysis treatment are restricting the growth of the market.
Europe Dialysis Equipment Market has been segmented and sub-segmented into the following categories
On the basis of type, the Hemodialysis segment dominates the market with over 88 % of the market share with dialyzers as its major segment during the forecast period. This is because of this method’s lower risk of infections. Peritoneal Dialysis Equipment is expected to grow at the fastest CAGR owing to the self-administrable and needleless treatment.
On the basis of end-user, the Homecare segment is expected to witness faster growth during the forecast period.
On the basis of region, Europe is the second-largest market after North America owing to the advanced infrastructure and higher medical reimbursement.
Prominent Companies leading the Europe Dialysis Equipment Market Profiled in the Report are Fresenius Medical Care AG & Co., Gambro AB, Baxter International Inc., Nipro Inc., ALL-MED Medical GmbH, Asahi Kasei Corporation, and others.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Hemodialysis Equipment
5.1.2.1 Hemodialysis Machines
5.1.2.2 Dialyzers
5.1.2.3 Blood Access Device Dialysate
5.1.3 Peritoneal Dialysis Equipment
5.1.3.1 Continuous Cycling Peritoneal Dialysis
5.1.3.2 Continuous Ambulatory Peritoneal Dialysis
5.1.3.3 Intermittent Peritoneal Dialysis
5.1.4 Continuous Renal Replacement Therapy Systems
5.1.5 Dialysis Accessories
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 End-User
5.3.1 Introduction
5.3.2 In-Center Dialysis
5.3.3 Homecare Dialysis
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
6.7 Rest of Europe
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Fresenius Medical Care AG & Co.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Gambro AB
8.3 Baxter International Inc.
8.4 Nipro Inc.
8.5 ALLMED Medical GmbH
8.6 Asahi Kasei Corporation
8.7 Celgene Corporation
8.8 Invitrogen
8.9 Cytori Therapeutics
8.10 Retractable Technologies
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
